BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Estcourt C, Yeung A, Nandwani R, Goldberg D, Cullen B, Steedman N, Wallace L, Hutchinson S. Population-level effectiveness of a national HIV preexposure prophylaxis programme in MSM. AIDS 2021;35:665-73. [PMID: 33290298 DOI: 10.1097/QAD.0000000000002790] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Cespedes MS, Das M, Yager J, Prins M, Krznaric I, de Jong J, Xiao D, Shao Y, Wong P, Kintu A, Carter C, Hoornenborg E, Ruane P, Phoenix J, Younis I, Halperin J. Gender Affirming Hormones Do Not Affect the Exposure and Efficacy of F/TDF or F/TAF for HIV Preexposure Prophylaxis: A Subgroup Analysis from the DISCOVER Trial. Transgender Health. [DOI: 10.1089/trgh.2022.0048] [Reference Citation Analysis]
2 Cui TS, Lane B, Wu Y, Ma J, Fu R, Hou J, Meng S, Xie L, Gu Y, Huang X, Zheng H, Ma Y, He N, Meyers K. Determinants of Willingness to Use PrEP Among Gay and Bisexual Men in China Before Implementation: A Structural Equation Modeling Assessment. AIDS Behav. [DOI: 10.1007/s10461-022-03815-1] [Reference Citation Analysis]
3 Lions C, Laroche H, Mora M, Pialoux G, Cotte L, Cua E, Piroth L, Molina JM, Salnikova M, Maradan G, Poizot-Martin I, Spire B. Missed opportunities for HIV pre-exposure prophylaxis among people with recent HIV infection: The French ANRS 95041 OMaPrEP study. HIV Med 2022. [PMID: 35943165 DOI: 10.1111/hiv.13367] [Reference Citation Analysis]
4 Grulich AE, Bavinton BR. Scaling up preexposure prophylaxis to maximize HIV prevention impact. Curr Opin HIV AIDS 2022;17:173-8. [PMID: 35762370 DOI: 10.1097/COH.0000000000000739] [Reference Citation Analysis]
5 Bragazzi NL, Khamisy-farah R, Tsigalou C, Mahroum N. HIV Pre-exposure Prophylaxis and Its Impact on the Gut Microbiome in Men Having Sex With Men. Front Microbiol 2022;13:922887. [DOI: 10.3389/fmicb.2022.922887] [Reference Citation Analysis]
6 Madhani A, Finlay KA. Using the COM-B model to characterize the barriers and facilitators of pre-exposure prophylaxis (PrEP) uptake in men who have sex with men. Br J Health Psychol 2022. [PMID: 35698439 DOI: 10.1111/bjhp.12605] [Reference Citation Analysis]
7 Ogaz D, Logan L, Curtis TJ, Mcdonagh L, Guerra L, Bradshaw D, Patel P, Macri C, Murphy G, Noel Gill O, Johnson AM, Nardone A, Burns F. PrEP use and unmet PrEP-need among men who have sex with men in London prior to the implementation of a national PrEP programme, a cross-sectional study from June to August 2019. BMC Public Health 2022;22. [DOI: 10.1186/s12889-022-13425-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Henderson L, Gibbs J, Quinn J, Ramasami S, Estcourt C. Maintaining access to HIV pre-exposure prophylaxis in a pandemic: A service evaluation of telephone-based pre-exposure prophylaxis provision. Int J STD AIDS 2022;33:718-21. [PMID: 35465791 DOI: 10.1177/09564624211068766] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Wang Y, Tanuma J, Li J, Iwahashi K, Peng L, Chen C, Hao Y, Gilmour S. Elimination of HIV transmission in Japanese MSM with combination interventions. The Lancet Regional Health - Western Pacific 2022;23:100467. [DOI: 10.1016/j.lanwpc.2022.100467] [Reference Citation Analysis]
10 Jourdain H, de Gage SB, Desplas D, Dray-spira R. Real-world effectiveness of pre-exposure prophylaxis in men at high risk of HIV infection in France: a nested case-control study. The Lancet Public Health 2022;7:e529-36. [DOI: 10.1016/s2468-2667(22)00106-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Saxton PJW, Azariah S, Cavadino A, Forster RF, Jenkins R, Werder SF, Southey K, Rich JG. Adherence, Sexual Behavior and Sexually Transmitted Infections in a New Zealand Prospective PrEP Cohort: 12 Months Follow-up and Ethnic Disparities. AIDS Behav 2022. [PMID: 35167038 DOI: 10.1007/s10461-022-03617-5] [Reference Citation Analysis]
12 Kojima N, Klausner JD. Preexposure prophylaxis is effective on a national level, but is it enough. AIDS 2021;35:691-2. [PMID: 33620874 DOI: 10.1097/QAD.0000000000002819] [Reference Citation Analysis]